Items per page
Sort by

Send to:

Choose Destination

Results: 7

Cited In for PubMed (Select 1442773)


Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.

Alani H, Tamimi A, Tamimi N.

World J Nephrol. 2014 Nov 6;3(4):156-68. doi: 10.5527/wjn.v3.i4.156. Review.


End-Stage Renal Disease and Renal Replacement Therapy in older Patients.

Smyth A.

Nephrourol Mon. 2012 Spring;4(2):425-30. doi: 10.5812/numonthly.1825. Epub 2012 Mar 1.


Survival trends of US dialysis patients with heart failure: 1995 to 2005.

Stack AG, Mohammed A, Hanley A, Mutwali A, Nguyen H.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1982-9. doi: 10.2215/CJN.01130211. Epub 2011 Jul 22.


Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Chan KE, Lazarus JM, Thadhani R, Hakim RM.

J Am Soc Nephrol. 2009 Oct;20(10):2223-33. doi: 10.1681/ASN.2009030319. Epub 2009 Aug 27.


Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.

Park S, Cho GY, Kim SG, Hwang YI, Kang HR, Jang SH, Kim DG, Song YR, Bae YA, Jung KS.

Crit Care. 2009;13(3):R70. doi: 10.1186/cc7878. Epub 2009 May 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk